Vaxart Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.1% | -3.4% | +28.3% | +46.5% | -0.2% | -4.7% | +3.5% | +27.4% | -11.0% | -3.2% | -8.3% | |
| – | -20.3% | -2.7% | +61.5% | -7.1% | +2.7% | -8.2% | +12.3% | +66.8% | +16.0% | -3.2% | -11.4% | |
| – | +4.6% | -23.1% | +61.9% | -49.1% | +14.5% | +13.8% | -29.9% | -16.1% | +218.8% | -5.7% | +0.4% | |
| – | -25.1% | -7.7% | +70.7% | -6.2% | -11.9% | -18.9% | -37.4% | +9.6% | +121.6% | -4.4% | +4.8% | |
| – | +609.4% | -23.8% | +108.4% | -23.0% | +225.6% | +34.7% | +154.7% | +109.3% | -40.3% | +12.1% | -18.4% | |
| – | -100.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -4.1% | -4.3% | -4.5% | -4.7% | -4.9% | -5.1% | -5.4% | -5.7% | -6.1% | -6.5% | -6.9% | |
| – | -0.3% | -3.1% | +2.3% | +191.2% | +9.4% | +5.1% | +16.2% | +38.9% | -46.1% | -12.6% | -3.6% | |
| – | +21.8% | +2.9% | +11.6% | +410.1% | +13.1% | +8.4% | +19.7% | +43.6% | -48.8% | -11.4% | -4.9% | |
| – | +68.6% | -20.7% | +7.7% | +1.3% | +26.8% | -54.4% | +7.0% | +8.5% | -21.3% | -15.0% | +0.4% | |
| – | +18.3% | +151.1% | -9.8% | -29.6% | +175.9% | +138.6% | -36.1% | +400.2% | -59.5% | +12.5% | -29.8% | |
| – | -19.2% | -3.7% | +43.7% | -14.5% | -13.9% | -22.6% | -27.9% | -18.6% | +228.1% | +7.2% | -12.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +28.4% | +0.1% | +0.2% | +0.2% | +0.6% | +5.1% | 0.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.